Reference · UMLS · 1
Letter 1
UMLS Metathesaurus concepts whose preferred name begins with 1. 5,155 entries.
UMLS · Letter 1
Letter 1
5,155 concepts whose preferred name begins with 1.
Showing 4,026–4,050 of 5,155
C114767414-3-3 Ag:ACnc:Pt:CSF:QnC094293214-3-3 Ag:ACnc:Pt:CSF:Qn:IAC150806414-3-3 Ag:MCnc:Pt:CSF:QnC583108014-3-3 Ag:MCnc:Pt:CSF:Qn:IAC114767314-3-3 Ag:PrThr:Pt:CSF:OrdC088136014-3-3 Ag:PrThr:Pt:CSF:Ord:IBC602071314-3-3 Ag:{Measurement}:-:CSF:-C009038814-3-3 ProteinsC515048214-3-3 eta Ag | Serum | Serology - non-microC387004014-3-3 eta Ag:MCnc:Pt:Ser:Qn:IAC455458714-3-3 eta antigenC515048314-3-3 protein | Cerebral spinal fluid | Serology - non-microC515048414-3-3 protein | Tissue and Smears | Serology - non-microC236052414-3-3 protein IB Ql (CSF)C474005914-3-3 protein:PrThr:Pt:Tiss:Ord:Probe.amp.tarC469948714-8-14-8C030821614-DAY FLEA AND TICK SPRAY (product)C515048514-Hydroxyclarithromycin | DBS | Drug toxicologyC515048614-Hydroxyclarithromycin | Serum or Plasma | Drug toxicologyC426610514-Hydroxyclarithromycin:MCnc:Pt:Bld.dot:QnC426610614-Hydroxyclarithromycin:MCnc:Pt:Ser/Plas:QnC384477614-day scheduled assessmentC009040914-hydroxyclarithromycinC541750214.5 ML atoltivimab-ebgn 16.7 MG/ML / maftivimab-ebgn 16.7 MG/ML / odesivimab-ebgn 16.7 MG/ML InjectionC541740114.5 ML atoltivimab-ebgn 16.7 MG/ML / maftivimab-ebgn 16.7 MG/ML / odesivimab-ebgn 16.7 MG/ML Injection [Inmazeb]
# same data, as API
GET /api/v1/reference/umls/search?q=1